fda glp-1 warning news september 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA Drug Recalls and Warnings:

Always consult a licensed healthcare professional before beginning any peptide protocol

To read the full report with deeper financial analysis and industry reactions, read the complete story at Mirror Review: Subscribe to Insight Digest If you found this analysis valuable, subscribe to Insight Digest for concise, fact-based breakdowns of major market shifts and global corporate strategy directly in your feed.

45.4% report vomiting

I.AlchJ

Main Outcomes and Measures Cox proportional hazard regression models were used to evaluate the primary outcome: association between GLP-1 RAs and the risk of incident DR, NAION, or sight-threatening complications over a 2-year follow-up period